The company said, “Based on all information available to date, the Company remains confident in its 2026 Individual MA pricing and benefit design, including the expectation that it will double individual MA pre-tax margin in 2026 (excluding Stars), and believes it is positioned to return to membership growth in 2026.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana says 20% of members in 4 stars or above MA plans for 2026
- Humana says ‘not satisfied’ with 2026 Medicare Advantage star ratings
- Humana still expects return to top quartile MA star ratings in 2027
- Humana price target lowered to $280 from $330 at BofA
- Trump Trade: White House announces drug pricing deal with Pfizer